ABSTRACT
Market access (MA) for drugs defines the rules that apply to allow a pharmaceutical company to enter a specific market. Those rules could be classified as generic rules that apply for all products and specific rules that aim to optimize a patient’s access to a specific drug. In this chapter, we discuss the latter case, and we call such arrangements between the manufacturers and the payers market access agreements (MAAs).
